Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Sticher

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Science Translational Medicine|October 25, 2019
Characterization of orally efficacious influenza drug with high resistance barrier in ferrets and human airway epitheliaMart Toots, Jeong-Joong Yoon, Robert M Cox, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2026
Developmental candidate GHP-88310/EIDD-3608 with high tolerability and oral efficacy in measles and respiratory paramyxovirus modelsCarolin M Lieber, Josef D Wolf, Mugunthan Govindarajan, et al.
Science Advances|May 22, 2026
Developmental candidate GHP-88310/EIDD-3608 with high tolerability and oral efficacy in measles and respiratory paramyxovirus modelsCarolin M Lieber, Josef D Wolf, Mugunthan Govindarajan, et al.
Plos Pathogens|April 17, 2023
4'-Fluorouridine mitigates lethal infection with pandemic human and highly pathogenic avian influenza virusesCarolin M Lieber, Megha Aggarwal, Jeong-Joong Yoon, et al.
Nature Communications|February 8, 2024
Therapeutic mitigation of measles-like immune amnesia and exacerbated disease after prior respiratory virus infections in ferretsRobert M Cox, Josef D Wolf, Nicole A Lieberman, et al.
Antimicrobial Agents and Chemotherapy|June 13, 2018
Orally Efficacious Broad-Spectrum Ribonucleoside Analog Inhibitor of Influenza and Respiratory Syncytial VirusesJeong-Joong Yoon, Mart Toots, Sujin Lee, et al.
ACS Medicinal Chemistry Letters|October 18, 2023
Design and Optimization of Novel Competitive, Non-peptidic, SARS-CoV-2 M<sup>pro</sup> InhibitorsLeon Jacobs, Aletta van der Westhuyzen, Nicole Pribut, et al.
European Journal of Medicinal Chemistry|February 25, 2026
Development of a nucleotide prodrug of 4'-fluorouridine to improve tolerabilityAustin T Ryan, Jean-Marc I A Lawrence, Brett Virgin-Downey, et al.
Science Translational Medicine|November 20, 2024
Delayed low-dose oral administration of 4'-fluorouridine inhibits pathogenic arenaviruses in animal models of lethal diseaseStephen R Welch, Jessica R Spengler, Jonna B Westover, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Science Translational Medicine|October 25, 2019
Characterization of orally efficacious influenza drug with high resistance barrier in ferrets and human airway epitheliaMart Toots, Jeong-Joong Yoon, Robert M Cox, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2026
Developmental candidate GHP-88310/EIDD-3608 with high tolerability and oral efficacy in measles and respiratory paramyxovirus modelsCarolin M Lieber, Josef D Wolf, Mugunthan Govindarajan, et al.
Science Advances|May 22, 2026
Developmental candidate GHP-88310/EIDD-3608 with high tolerability and oral efficacy in measles and respiratory paramyxovirus modelsCarolin M Lieber, Josef D Wolf, Mugunthan Govindarajan, et al.
Plos Pathogens|April 17, 2023
4'-Fluorouridine mitigates lethal infection with pandemic human and highly pathogenic avian influenza virusesCarolin M Lieber, Megha Aggarwal, Jeong-Joong Yoon, et al.
Nature Communications|February 8, 2024
Therapeutic mitigation of measles-like immune amnesia and exacerbated disease after prior respiratory virus infections in ferretsRobert M Cox, Josef D Wolf, Nicole A Lieberman, et al.
Antimicrobial Agents and Chemotherapy|June 13, 2018
Orally Efficacious Broad-Spectrum Ribonucleoside Analog Inhibitor of Influenza and Respiratory Syncytial VirusesJeong-Joong Yoon, Mart Toots, Sujin Lee, et al.
ACS Medicinal Chemistry Letters|October 18, 2023
Design and Optimization of Novel Competitive, Non-peptidic, SARS-CoV-2 M<sup>pro</sup> InhibitorsLeon Jacobs, Aletta van der Westhuyzen, Nicole Pribut, et al.
European Journal of Medicinal Chemistry|February 25, 2026
Development of a nucleotide prodrug of 4'-fluorouridine to improve tolerabilityAustin T Ryan, Jean-Marc I A Lawrence, Brett Virgin-Downey, et al.
Science Translational Medicine|November 20, 2024
Delayed low-dose oral administration of 4'-fluorouridine inhibits pathogenic arenaviruses in animal models of lethal diseaseStephen R Welch, Jessica R Spengler, Jonna B Westover, et al.
Pageof 2